XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 103 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $382,899 | +15.0% | 170,937 | +12.9% | 0.03% | +18.5% |
| Q1 2024 | $333,069 | -6.4% | 151,395 | 0.0% | 0.03% | +12.5% |
| Q4 2023 | $355,778 | +26.3% | 151,395 | 0.0% | 0.02% | +60.0% |
| Q3 2023 | $281,595 | -28.7% | 151,395 | 0.0% | 0.02% | -28.6% |
| Q2 2023 | $395,141 | +61.1% | 151,395 | 0.0% | 0.02% | +50.0% |
| Q1 2023 | $245,260 | +22.7% | 151,395 | 0.0% | 0.01% | +180.0% |
| Q4 2022 | $199,841 | -15.3% | 151,395 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $236,000 | +1.7% | 151,395 | 0.0% | 0.01% | -25.0% |
| Q2 2022 | $232,000 | -40.2% | 151,395 | 0.0% | 0.01% | -38.5% |
| Q1 2022 | $388,000 | -12.0% | 151,395 | 0.0% | 0.01% | -7.1% |
| Q4 2021 | $441,000 | – | 151,395 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,113,348 | $11,505,033 | 58.31% |
| Rosalind Advisors, Inc. | 3,120,170 | $7,020,382 | 5.40% |
| MPM BioImpact LLC | 4,830,526 | $10,868,684 | 1.69% |
| Knott David M Jr | 820,000 | $1,845 | 0.74% |
| CenterBook Partners LP | 1,465,875 | $3,298,219 | 0.20% |
| Redmile Group, LLC | 1,046,587 | $2,354,821 | 0.14% |
| Alpine Global Management, LLC | 300,000 | $675,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 605,663 | $1,363 | 0.10% |
| Invenomic Capital Management LP | 592,078 | $1,332,176 | 0.06% |
| Powell Investment Advisors, LLC | 50,000 | $112,500 | 0.06% |